ADI vs DMAC · P/E 61, rev $11.02B vs $157.4M cap
Analog Devices Inc (ADI) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
DMAC does not have a complete income-statement cache yet.
ADI currently screens at market cap $201.87B and trailing P/E 61.5. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the ADI and DMAC stock pages for the full models.
Not investment advice.